CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Vertex Pharmaceuticals Incorporated (VRTX) will report its second quarter 2013 financial results on Monday, July 29, 2013 after the financial markets close. The company will host a conference call and webcast at 5:00 p.m. ET.
The conference call will be webcast live and a link to the webcast may be accessed from the “Vertex Events” page of Vertex’s website at www.vrtx.com. A replay of the conference call and webcast will be archived on the company’s website until August 5, 2013. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, Mass., we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and for three years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. Vertex’s press releases are available at www.vrtx.com.
- Health Care Industry
- Company Earnings
Michael Partridge, 617-341-6108
Kelly Lewis, 617-961-7530
Zach Barber, 617-341-6470